GBMA welcomes PBS listing of infliximab

inflectra story, checkered race winning flag
The inclusion of the first monoclonal antibody biosimilar on the PBS will deliver immediate savings to the Federal Government; however the full potential of this and other biosimilar medicines relies on market uptake drivers aimed at prescribers, pharmacists and patients, says the Generic and Biosimilar Medicines Association. GBMA welcomed today’s PBS listing of Inflectra (infliximab)

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous DDS donates $11,000+ to McGrath Foundation
Next Medication reviews for people with intellectual disability